Oncotelic Therapeutics (OTCQB: OTLC) (@oncotelic) 's Twitter Profile
Oncotelic Therapeutics (OTCQB: OTLC)

@oncotelic

Healthy Human/ Happy Pets/ Ageless and Cancer Free. $OTLC

ID: 735556326491860993

linkhttp://www.oncotelic.com calendar_today25-05-2016 19:41:09

1,1K Tweet

636 Followers

231 Following

Oncotelic Therapeutics (OTCQB: OTLC) (@oncotelic) 's Twitter Profile Photo

Just dropped: a user-friendly blog and a third-party podcast now live in our Content Hub on Discord. You can also interact with the chatbot about Vuong’s presentation World Cancer Research (SWCR 2025) in Kyoto. Join the conversation: discord.gg/jz6Q7G2SBQ

Oncotelic Therapeutics (OTCQB: OTLC) (@oncotelic) 's Twitter Profile Photo

Explore the highlights from Dr. Vuong Trieu's recent presentation at the 2025 Symposium on World Cancer Research, covering OT-101’s potential to target TGF-β2 in pancreatic cancer and glioblastoma. Read the full insights here: medium.com/@blog_19647/pr…

Cancers MDPI (@cancers_mdpi) 's Twitter Profile Photo

💬You are invited to explore the impact of TGFB2 Methylation in GBM on Discord at discord.com/invite/gWrUz3P… for the paper available online at👉 mdpi.com/2072-6694/17/7… 👥by Sanjive Qazi et al. Oncotelic Therapeutics (OTCQB: OTLC)

💬You are invited to explore the impact of TGFB2 Methylation in GBM on Discord at discord.com/invite/gWrUz3P… for the paper available online at👉 mdpi.com/2072-6694/17/7…
👥by Sanjive Qazi et al. <a href="/Oncotelic/">Oncotelic Therapeutics (OTCQB: OTLC)</a>
Oncotelic Therapeutics (OTCQB: OTLC) (@oncotelic) 's Twitter Profile Photo

Oncotelic Therapeutics Showcases Robust Pipeline and Founder’s Broad Intellectual Property Contributions to Biopharma Industry, highlighting multibillion-dollar drug discoveries and advancing novel oncology and immunotherapy assets. $OTLC otcmarkets.com/stock/OTLC/new…

Oncotelic Therapeutics (OTCQB: OTLC) (@oncotelic) 's Twitter Profile Photo

Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics’ Commitment to Innovation, Life-Saving Therapies $OTLC otcmarkets.com/stock/OTLC/new…

Oncotelic Therapeutics (OTCQB: OTLC) (@oncotelic) 's Twitter Profile Photo

Oncotelic Therapeutics Highlights 2 Years of Clinical and Regulatory Advancements Across Late-Stage Pipeline $OTLC oncotelic.com/press-releases/

Oncotelic Therapeutics (OTCQB: OTLC) (@oncotelic) 's Twitter Profile Photo

New Podcast: Dr. Trieu joins BioMedWire to talk biotech, innovation, and the future of oncology. From navigating clinical trials to tackling the toughest challenges in cancer treatment, his insights reveal why this work matters far beyond the lab. $OTLC

Oncotelic Therapeutics (OTCQB: OTLC) (@oncotelic) 's Twitter Profile Photo

Oncotelic Advances to Phase 1 Human Clinical Trials New Injectable Formulation for Treating Breast Cancer $OTLC oncotelic.com/press-releases/

Oncotelic Therapeutics (OTCQB: OTLC) (@oncotelic) 's Twitter Profile Photo

New Podcast: Dr. Trieu joins BioMedWire to discuss Oncotelic’s major update on the latest clinical milestone: the advancement of Sapu-003, a novel IV formulation of everolimus (Afinitor®) built on Oncotelic’s proprietary Deciparticle™ platform. $OTLC oncotelic.com